- More than double the number of drug import field examinations
- 346 new hires for the signature Safer Medical Products initiative
- A 43 per cent increase in foreign GMP surveillance inspections
- New field offices in New Delhi, Beijing, Shanghai, Mexico, Costa Rica and other overseas hot-spots, manned by at least 60 staffers
Although XStream is supportive of increased enforcement and inspection, we encourage all commercial members of the pharmaceutical supply chain to increase their screening, verification and authentication of materials and products. Protecting your brand beyond regulatory enforcement is the key to success and avoidance of catastrophic failures within the supply chain.